← SynDRA
HA14.1
SynDRA canonical compound SYN1970487 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | BCL2 |
| Mechanism of action | bcl inhibitor |
| Indication | acute myeloid leukemia (aml) |
| Disease area | Oncology |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- ha14-1
- Ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate
- HA-14-1
- Ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-1-benzopyran-3-carboxylate
- (alphaR,4R)-rel-2-amino-6-bromo-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-aceticacid,ethylester
- SR-01000511000
- Maybridge1_000786
- MFCD00218213
- BSPBio_001583
- KBioGR_000303
- KBioSS_000303
- SCHEMBL1427458
- CHEBI:94328
- HMS543L16
- KBio2_000303
- KBio2_002871
- KBio2_005439
- KBio3_000605
- KBio3_000606
- DTXSID20274403
- EX-A148
- Bio2_000303
- Bio2_000783
- HMS1361P05
- HMS1791P05
- HMS1989P05
- HMS3268C09
- HMS3414M05
- HMS3678M05
- BCP01804
- BTB 02933
- HA 141
- HSCI1_000186
- NSC720569
- AKOS007930839
- BCP9000758
- CCG-233971
- NSC-720569
- IDI1_034053
Look up HA14.1 in the interactive SynDRA portal →